natgillin/translations-raw huggingface dataset:
Declaration of the producer or authorised representative or, where applicable, the third party acting on the behalf of the producer or authorised representative that the information provided is true and accurate.
Osoba povezana s proizvođačem ili ovlaštenim predstavnikom ili, ako je primjenjivo, s organizacijom koja provodi obveze proširene odgovornosti proizvođača u ime proizvođača, koja je odabrana kao početna ili stalna kontaktna točka za izvješćivanje u registar.
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-naphthylacetamide, 1-naphthylacetic acid, acrinathrin, azoxystrobin, fluazifop p, fluroxypyr, imazalil, kresoxim-methyl, oxyfluorfen, prochloraz, prohexadione, spiroxamine, tefluthrin and terbuthylazine
o izmjeni Provedbene uredbe (EU) br. 540/2011 u pogledu produljenja roka važenja odobrenja aktivnih tvari 1-naftilacetamid, 1-naftil-octena kiselina, akrinatrin, azoksistrobin, fluazifop-P, fluroksipir, imazalil, krezoksim-metil, oksifluorfen, prokloraz, proheksadion, spiroksamin, teflutrin i terbutilazin
Part B of the Annex to Commission Implementing Regulation (EU) No 540/2011 sets out the active substances approved under Regulation (EC) No 1107/2009.
U dijelu B Priloga Provedbenoj uredbi Komisije (EU) br. 540/2011 utvrđene su aktivne tvari koje su odobrene na temelju Uredbe (EZ) br. 1107/2009.
The approval periods of the substances 1-naphthylacetamide, 1-naphthylacetic acid, acrinathrin, azoxystrobin, fluazifop p, fluroxypyr, imazalil, kresoxim-methyl, oxyfluorfen, prochloraz, prohexadione, spiroxamine, tefluthrin and terbuthylazine will expire on 31 December 2021.
Rok važenja odobrenja aktivnih tvari 1-naftilacetamid, 1-naftil-octena kiselina, akrinatrin, azoksistrobin, fluazifop-P, fluroksipir, imazalil, krezoksim-metil, oksifluorfen, prokloraz, proheksadion, spiroksamin, teflutrin i terbutilazin istječe 31. prosinca 2021.
Applications for the renewal of the approval of the active substances included in this Regulation were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012.
Podneseni su zahtjevi za produljenje odobrenja aktivnih tvari navedenih u ovoj Uredbi u skladu s Provedbenom uredbom Komisije (EU) br. 844/2012.
In view of the time and resources necessary for completing the assessment of the applications for the renewal of approval of a large number of active substances the approvals of which will expire between 2019 and 2021, Commission Implementing Decision C(2016) 6104 established a work programme grouping together similar active substances and setting priorities on the basis of safety concerns for human and animal health or the environment as provided for in Article 18 of Regulation (EC) No 1107/2009.
Uredbe (EZ) br. 1107/2009.
The presumed low risk substances should be prioritised in accordance with Implementing Decision C(2016) 6104.
S obzirom na vrijeme i sredstva koji su potrebni za dovršenje procjene zahtjevâ za produljenje odobrenja velikog broja aktivnih tvari za koje odobrenja istječu između 2019. i 2021., Provedbenom odlukom Komisije C(2016)6104 utvrđen je program rada u kojemu se grupiraju slične aktivne tvari i određuju prioriteti na temelju pitanjâ sigurnosti za zdravlje ljudi i životinja ili za okoliš, kako je predviđeno člankom 18.
Taking into account the distribution of responsibilities and work among the Member States acting as rapporteurs and co-rapporteursand the available resources necessary for assessment and decision-making, that period should be of one year for the active substance prohexadione.
Tvarima za koje se smatra da su manjeg rizika treba dati prioritet u skladu s Provedbenom odlukom C(2016)6104.
For the active substances which do not fall in the prioritised categories in Implementing Decision C(2016) 6104, the approval period should be extended by either two or three years, taking into account the current date of expiry, the fact that in accordance with Article 6(3) of Implementing Regulation (EU) No 844/2012, the supplementary dossier for an active substance is to be submitted no later than 30 months before the expiry of the approval, taking into account the need to ensure a balanced distribution of responsibilities and work among the Member States acting as rapporteurs and co-rapporteurs and the available resources necessary for assessment and decision-making.
Stoga bi odobrenje za te tvari trebalo produljiti za najkraće moguće razdoblje.
It is therefore appropriate to extend the approval periods for the active substances 1-naphthylacetamide, 1-naphthylacetic acid, acrinathrin, fluazifop p, prochloraz and spiroxamine by two years, and to extend the approval periods of the active substances azoxystrobin, fluroxypyr, imazalil, kresoxim-methyl, oxyfluorfen, tefluthrin, terbuthylazine by three years.
Uzimajući u obzir raspodjelu odgovornosti i rada među državama članicama koje djeluju kao izvjestiteljice i suizvjestiteljice te dostupne resurse potrebne za procjenu i donošenje odluke, to bi razdoblje za aktivnu tvar proheksadion trebalo trajati jednu godinu.
In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where no supplementary dossier in accordance with Implementing Regulation (EU) No 844/2012 is submitted no later than 30 months before the respective expiry date laid down in the Annex to this Regulation, the Commission will set the expiry date at the same date as before this Regulation or at the earliest date thereafter.
Za aktivne tvari koje nisu obuhvaćene prioritetnim kategorijama u Provedbenoj odluci C(2016)6104 rok važenja odobrenja trebalo bi produljiti za dvije ili tri godine, uzimajući u obzir postojeći datum isteka odobrenja, činjenicu da se u skladu s člankom 6. stavkom 3.
In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later.
Provedbene uredbe (EU) br. 844/2012 dopunska dokumentacija za aktivnu tvar treba dostaviti najkasnije 30 mjeseci prije isteka odobrenja, uzimajući u obzir potrebu da se osigura ujednačena raspodjela odgovornosti i rada među državama članicama koje djeluju kao izvjestiteljice i suizvjestiteljice te raspoložive resurse potrebne za procjenu i donošenje odluke.
As regards cases where the Commission will adopt a Regulation providing for the renewal of an active substance referred to in the Annex to this Regulation, the Commission will endeavour to set, as appropriate under the circumstances, the earliest possible application date.
Stoga je primjereno produljiti rok važenja odobrenja za aktivne tvari 1-naftilacetamid, 1-naftil-octena kiselina, akrinatrin, fluazifop-P, prokloraz i spiroksamin za dvije godine, a za aktivne tvari azoksistrobin, fluroksipir, imazalil, krezoksim-metil, oksifluorfen, teflutrin i terbutilazin za tri godine.
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
S obzirom na cilj članka 17. prvog stavka Uredbe (EZ) br. 1107/2009, u slučajevima u kojima Komisija donese uredbu kojom se predviđa da se odobrenje aktivne tvari iz Priloga ovoj Uredbi ne produljuje jer nisu ispunjena mjerila za odobravanje, Komisija kao datum isteka određuje isti datum koji je vrijedio prije donošenja ove Uredbe ili datum stupanja na snagu uredbe kojom se predviđa da se odobrenje aktivne tvari ne produljuje, ovisno o tome koji je datum kasniji.
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Mjere predviđene u ovoj Uredbi u skladu su s mišljenjem Stalnog odbora za bilje, životinje, hranu i hranu za životinje,
Done at Brussels, 19 February 2019.
Članak 2.
OJ L 309, 24.11.2009, p. 1.
Sastavljeno u Bruxellesu 19. veljače 2019.
in the sixth column, expiration of approval, of row 4, Azoxystrobin, the date is replaced by ‘31 December 2024’;
Provedbena odluka Komisije оd 28. rujna 2016. o uspostavi programa rada za procjenu zahtjeva za produljenje odobrenja aktivnih tvari koja istječu u 2019., 2020. i 2021. u skladu s Uredbom (EZ) br. 1107/2009 Europskog parlamenta i Vijeća (SL C 357, 29.9.2016., str. 9.).
in the sixth column, expiration of approval, of row 5, Imazalil, the date is replaced by ‘31 December 2024’;
PRILOG
in the sixth column, expiration of approval, of row 6, Prohexadione, the date is replaced by ‘31 December 2022’
Dio B Priloga Provedbenoj uredbi (EU) br. 540/2011 mijenja se kako slijedi:
in the sixth column, expiration of approval, of row 7, Spiroxamine, the date is replaced by ‘31 December 2023’;
U šestom stupcu, prestanak odobrenja, u retku 4., azoksistrobin, datum se zamjenjuje datumom „31. prosinca 2024.”
in the sixth column, expiration of approval, of row 8, Kresoxim-methyl, the date is replaced by ‘31 December 2024’;
U šestom stupcu, prestanak odobrenja, u retku 5., imazalil, datum se zamjenjuje datumom „31. prosinca 2024.”
in the sixth column, expiration of approval, of row 9, Fluroxypyr, the date is replaced by ‘31 December 2024’;
U šestom stupcu, prestanak odobrenja, u retku 6., proheksadion, datum se zamjenjuje datumom „31. prosinca 2022.”
in the sixth column, expiration of approval, of row 10, Tefluthrin, the date is replaced by ‘31 December 2024’;
U šestom stupcu, prestanak odobrenja, u retku 7., spiroksamin, datum se zamjenjuje datumom „31. prosinca 2023.”
in the sixth column, expiration of approval, of row 11, Oxyfluorfen, the date is replaced by ‘31 December 2024’;
U šestom stupcu, prestanak odobrenja, u retku 8., krezoksim-metil, datum se zamjenjuje datumom „31. prosinca 2024.”
in the sixth column, expiration of approval, of row 12, 1-naphthylacetamide, the date is replaced by ‘31 December 2023’;
U šestom stupcu, prestanak odobrenja, u retku 9., fluroksipir, datum se zamjenjuje datumom „31. prosinca 2024.”
in the sixth column, expiration of approval, of row 13, 1-naphthylacetic acid, the date is replaced by ‘31 December 2023’;
U šestom stupcu, prestanak odobrenja, u retku 10., teflutrin, datum se zamjenjuje datumom „31. prosinca 2024.”
in the sixth column, expiration of approval, of row 15, Fluazifop P, the date is replaced by ‘31 December 2023’;
U šestom stupcu, prestanak odobrenja, u retku 11., oksifluorfen, datum se zamjenjuje datumom „31. prosinca 2024.”
in the sixth column, expiration of approval, of row 16, Terbuthylazine, the date is replaced by ‘31 December 2024’;
U šestom stupcu, prestanak odobrenja, u retku 12., 1-naftilacetamid, datum se zamjenjuje datumom „31. prosinca 2023.”
in the sixth column, expiration of approval, of row 19, Acrinathrin, the date is replaced by ‘31 December 2023’;
U šestom stupcu, prestanak odobrenja, u retku 13., 1-naftil-octena kiselina, datum se zamjenjuje datumom „31. prosinca 2023.”
in the sixth column, expiration of approval, of row 20, Prochloraz, the date is replaced by ‘31 December 2023’.
U šestom stupcu, prestanak odobrenja, u retku 15., fluazifop-P, datum se zamjenjuje datumom „31. prosinca 2023.”
amending Implementing Regulation (EU) No 1011/2014 as regards changes to the model for the payment application including additional information concerning financial instruments and to the model for the accounts
o izmjeni Provedbene uredbe (EU) br. 1011/2014 u pogledu promjena modela zahtjeva za plaćanje uključujući dodatno izvješćivanje o financijskim instrumentima i modela za račune
Having regard to Regulation (EU) No 1303/2013 of the European Parliament and of the Council of 17 December 2013 laying down common provisions on the European Regional Development Fund, the European Social Fund, the Cohesion Fund, the European Agricultural Fund for Rural Development and the European Maritime and Fisheries Fund and laying down general provisions on the European Regional Development Fund, the European Social Fund, the Cohesion Fund and the European Maritime and Fisheries Fund and repealing Council Regulation (EC) No 1083/2006, and in particular Article 41(4), Article 131(6) and Article 137(3) thereof,
uzimajući u obzir Uredbu (EU) br. 1303/2013 Europskog parlamenta i Vijeća od 17. prosinca 2013. o utvrđivanju zajedničkih odredbi o Europskom fondu za regionalni razvoj, Europskom socijalnom fondu, Kohezijskom fondu, Europskom poljoprivrednom fondu za ruralni razvoj i Europskom fondu za pomorstvo i ribarstvo i o utvrđivanju općih odredbi o Europskom fondu za regionalni razvoj, Europskom socijalnom fondu, Kohezijskom fondu i Europskom fondu za pomorstvo i ribarstvo te o stavljanju izvan snage Uredbe Vijeća (EZ) br. 1083/2006, a posebno njezin članak 41. stavak 4., članak 131. stavak 6. i članak 137. stavak 3.,
Annex VI to Commission Implementing Regulation (EU) No 1011/2014 sets out the model for the payment application including additional information concerning financial instruments in accordance with Article 131(6) of Regulation (EU) No 1303/2013.
U Prilogu VI.
With regard to advances paid in the context of State aid, Appendix 2 to that Annex specifies what amount of those advances paid and then in turn covered or not by expenditure paid by beneficiaries within a given period should be included into the payment applications.
Provedbenoj uredbi Komisije (EU) br. 1011/2014 utvrđuje se model zahtjeva za plaćanje uključujući dodatno izvješćivanje o financijskim instrumentima u skladu s člankom 131. stavkom 6.
Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council amended the definition of ‘beneficiary’ in Regulation (EU) No 1303/2013.
Uredbe (EU) br. 1303/2013.
It also amended Article 131(3) of Regulation (EU) No 1303/2013, which now provides that in the case of State aid, the public contribution corresponding to the expenditure included in a payment application is to have been paid to the beneficiaries by the body granting the aid or, where Member States have decided that the beneficiary is the body granting the aid pursuant to point (a) of Article 2(10) of that Regulation, paid by the beneficiary to the body receiving the aid.
U pogledu predujmova plaćenih u kontekstu državne potpore, u Dodatku 2. tom Prilogu navodi se koliki iznos tih predujmova plaćenih i zatim pokrivenih ili nepokrivenih rashodima koje plaćaju korisnici u određenom roku treba biti uključen u zahtjeve za plaćanje.
Due to those changes, Appendix 2 to Annex VI to Implementing Regulation (EU) No 1011/2014 should be amended accordingly.
Uredbom (EU, Euratom) 2018/1046 Europskog parlamenta i Vijeća izmijenjena je definicija „korisnika” iz Uredbe (EU) br. 1303/2013.
Annex VII to Implementing Regulation (EU) No 1011/2014 sets out the model for the accounts in accordance with Article 137(3) of Regulation (EU) No 1303/2013.
Nadalje, izmijenjen je članak 131. stavak 3.
With regard to advances paid in the context of State aid, Appendix 7 to that Annex specifies what amount of those advances paid and then in turn covered or not by expenditure paid by beneficiaries within a given period is to be included into the accounts.
Uredbe (EU) br. 1303/2013, kojim je sada predviđeno da u slučaju državne potpore javni doprinos koji odgovara izdacima uključenima u zahtjev za plaćanje korisnicima plaća tijelo koje dodjeljuje potporu ili, ako su države članice u skladu s člankom 2. točkom 10. podtočkom (a) odlučile da je tijelo koje dodjeljuje potporu ujedno korisnik, korisnik plaća tijelu koje prima potporu.
With regard to the total amount of eligible expenditure entered into the accounting systems of the certifying authority which has been included in payment applications, point (a) of Article 137(1) of Regulation (EU) No 1303/2013 refers back to its Article 131.
Zbog tih bi izmjena Dodatak 2.
Due to the changes in Article 131(3) of that Regulation, Appendix 7 to Annex VII to Implementing Regulation (EU) No 1011/2014 should also be amended accordingly.
Prilogu VI.
In order to ensure legal certainty and to limit discrepancies between the amended provisions of Regulation (EU) No 1303/2013 which apply from 2 August 2018 or earlier in accordance with Article 282 of Regulation (EU, Euratom) 2018/1046 and the provisions of this Regulation to a minimum, this Regulation should enter into force on the day following that of its publication in the Official Journal of the European Union.
Provedbenoj uredbi (EU) br. 1011/2014 trebalo na odgovarajući način izmijeniti.
The measures provided for in this Regulation are in accordance with the opinion of the Coordination Committee for the European Structural and Investment Funds.
U Prilogu VII.
Implementing Regulation (EU) No 1011/2014 should therefore be amended accordingly,
Provedbenoj uredbi (EU) br. 1011/2014 utvrđuje se model za račune u skladu s člankom 137. stavkom 3.
HAS ADOPTED THIS REGULATION:
Uredbe (EU) br. 1303/2013.
Article 1
U pogledu predujmova plaćenih u kontekstu državne potpore, u Dodatku 7. tom Prilogu navodi se koliki iznos tih predujmova plaćenih i zatim pokrivenih ili nepokrivenih rashodima koje plaćaju korisnici u određenom roku treba biti uključen u račune.
Annexes VI and VII to Implementing Regulation (EU) No 1011/2014 are amended in accordance with the Annex to this Regulation.
U pogledu ukupnog iznosa prihvatljivih izdataka evidentiranog u računovodstvenim sustavima tijela za ovjeravanje koji je uključen u zahtjev za plaćanje, u članku 137. stavku 1. točki (a) Uredbe (EU) br. 1303/2013 upućuje se na članak 131. iste uredbe.
Article 2
Zbog izmjena članka 131. stavka 3. te uredbe Dodatak 7.
This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.
Prilogu VII.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Provedbenoj uredbi (EU) br. 1011/2014 trebalo bi na odgovarajući način izmijeniti.
Done at Brussels, 20 February 2019.
Kako bi se osigurala pravna sigurnost te kako bi se neusklađenosti između izmijenjenih odredaba Uredbe (EU) br. 1303/2013 koje se primjenjuju od 2. kolovoza 2018. ili ranije u skladu s člankom 282.
For the Commission
Uredbe (EU, Euratom) 2018/1046 i odredaba ove Uredbe ograničile na najmanju mjeru, Uredba bi trebala stupiti na snagu sljedećeg dana od dana objave u Službenom listu Europske unije.
The President
Mjere predviđene u ovoj Uredbi u skladu su s mišljenjem Koordinacijskog odbora za europske strukturne i investicijske fondove.
OJ L 347, 20.12.2013, p. 320.
Provedbenu uredbu (EU) br. 1011/2014 trebalo bi stoga na odgovarajući način izmijeniti,
Commission Implementing Regulation (EU) No 1011/2014 of 22 September 2014 laying down detailed rules for implementing Regulation (EU) No 1303/2013 of the European Parliament and of the Council as regards the models for submission of certain information to the Commission and the detailed rules concerning the exchanges of information between beneficiaries and managing authorities, certifying authorities, audit authorities and intermediate bodies (OJ L 286, 30.9.2014, p. 1).
DONIJELA JE OVU UREDBU:
Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July 2018 on the financial rules applicable to the general budget of the Union, amending Regulations (EU) No 1296/2013, (EU) No 1301/2013, (EU) No 1303/2013, (EU) No 1304/2013, (EU) No 1309/2013, (EU) No 1316/2013, (EU) No 223/2014, (EU) No 283/2014, and Decision No 541/2014/EU and repealing Regulation (EU, Euratom) No 966/2012 (OJ L 193, 30.7.2018, p. 1).
Članak 1.
ANNEX
Prilozi VI. i VII.
Annexes VI and VII are amended as follows:
Provedbenoj uredbi (EU) br. 1011/2014 mijenjaju se u skladu s Prilogom ovoj Uredbi.
in Annex VI, Appendix 2 is amended as follows:
Članak 2.
the heading of column (B) is replaced by the following:
Ova Uredba stupa na snagu sljedećeg dana od dana objave u Službenom listu Europske unije.
‘Amount which has been covered by expenditure paid by beneficiaries or, where Member States have decided that the beneficiary is the body granting the aid pursuant to point (a) of Article 2(10) of Regulation (EU) No 1303/2013, by the body receiving the aid, within three years of the payment of the advance’;
Ova je Uredba u cijelosti obvezujuća i izravno se primjenjuje u svim državama članicama.
the heading of column (C) is replaced by the following:
Sastavljeno u Bruxellesu 20. veljače 2019.
‘Amount which has not been covered by expenditure paid by beneficiaries or, where Member States have decided that the beneficiary is the body granting the aid pursuant to point (a) of Article 2(10) of Regulation (EU) No 1303/2013, by the body receiving the aid, and for which the three year period has not yet elapsed’;
Za Komisiju
in Annex VII, Appendix 7 is amended as follows:
Predsjednik
‘Amount which has not been covered by expenditure paid by beneficiaries or, where Member States have decided that the beneficiary is the body granting the aid pursuant to point (a) of Article 2(10) of Regulation (EU) No 1303/2013, by the body receiving the aid, and for which the three year period has not yet elapsed’.
SL L 347, 20.12.2013., str. 320.
correcting certain language versions of Implementing Regulation (EU) 2016/2286 laying down detailed rules on the application of fair use policy and on the methodology for assessing the sustainability of the abolition of retail roaming surcharges and on the application to be submitted by a roaming provider for the purposes of that assessment
o izmjeni određenih jezičnih verzija Provedbene uredbe (EU) 2016/2286 o utvrđivanju detaljnih pravila o primjeni politike pravedne uporabe, o metodologiji procjene održivosti ukidanja maloprodajnih dodatnih naknada za roaming te o zahtjevu koji podnosi pružatelj usluga roaminga za potrebe te procjene
Having regard to Regulation (EU) No 531/2012 of the European Parliament and of the Council of 13 June 2012 on roaming on public mobile communications networks within the Union, and in particular Article 6d(1) thereof,
uzimajući u obzir Uredbu (EU) br. 531/2012 Europskog parlamenta i Vijeća od 13. lipnja 2012. o roamingu u javnim pokretnim komunikacijskim mrežama u Uniji, a posebno njezin članak 6.d stavak 1.,
The Dutch, Greek and Portuguese language versions of Commission Implementing Regulation (EU) 2016/2286 contain an error in the first subparagraph of Article 4(2) as regards the calculation of the minimum volume of data roaming retail services the roaming customer is to be able to consume when periodically travelling in the Union, in case a fair use policy is applied by the roaming provider.
Verzije Provedbene uredbe Komisije (EU) 2016/2286 na nizozemskom, grčkom i portugalskom jeziku u članku 4. stavku 2. prvom podstavku sadržavaju pogrešku u izračunu najmanje količine maloprodajnih podatkovnih usluga roaminga kojima se korisnik roaminga koji povremeno putuje unutar Unije može koristiti ako pružatelj usluga roaminga primjenjuje politiku pravedne uporabe.
The Dutch, Greek and Portuguese language versions of Implementing Regulation (EU) 2016/2286 should therefore be corrected accordingly.
Verzije Provedbene uredbe (EU) 2016/2286 na nizozemskom, grčkom i portugalskom jeziku trebalo bi stoga na odgovarajući način ispraviti.
Done at Brussels, 20 February 2019.
Sastavljeno u Bruxellesu 20. veljače 2019.
Commission Implementing Regulation (EU) 2016/2286 of 15 December 2016 laying down detailed rules on the application of fair use policy and on the methodology for assessing the sustainability of the abolition of retail roaming surcharges and on the application to be submitted by a roaming provider for the purposes of that assessment (OJ L 344, 17.12.2016, p. 46).
Provedbena uredba Komisije (EU) 2016/2286 оd 15. prosinca 2016. o utvrđivanju detaljnih pravila o primjeni politike pravedne uporabe, o metodologiji procjene održivosti ukidanja maloprodajnih dodatnih naknada za roaming te o zahtjevu koji podnosi pružatelj usluga roaminga za potrebe te procjene (SL L 344, 17.12.2016., str. 46.).